Ameriprise’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Buy |
242,760
+46,877
| +24% | +$2.39M | ﹤0.01% | 1657 |
|
|
2025
Q1 | $8.82M | Buy |
195,883
+1,807
| +0.9% | +$81.4K | ﹤0.01% | 1853 |
|
|
2024
Q4 | $8.02M | Buy |
194,076
+10,732
| +6% | +$444K | ﹤0.01% | 1977 |
|
|
2024
Q3 | $7.15M | Buy |
183,344
+168,037
| +1,098% | +$6.55M | ﹤0.01% | 2104 |
|
|
2024
Q2 | $523K | Sell |
15,307
-3,720
| -20% | -$127K | ﹤0.01% | 3401 |
|
|
2024
Q1 | $478K | Sell |
19,027
-11,550
| -38% | -$290K | ﹤0.01% | 3434 |
|
|
2023
Q4 | $903K | Buy |
30,577
+180
| +0.6% | +$5.31K | ﹤0.01% | 3225 |
|
|
2023
Q3 | $961K | Buy |
30,397
+13,314
| +78% | +$421K | ﹤0.01% | 3159 |
|
|
2023
Q2 | $442K | Sell |
17,083
-1,882
| -10% | -$48.7K | ﹤0.01% | 3485 |
|
|
2023
Q1 | $456K | Buy |
+18,965
| New | +$456K | ﹤0.01% | 3464 |
|